Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report

Anaemia is a common occurrence in patients with cancer, and currently can be treated in several ways. Novel erythropoiesis stimulating protein (NESP, darbepoetin alfa) was created using site-directed mutagenesis to have 8 more sialic acid side chains than recombinant human erythropoietin (rHuEPO). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Heatherington, A C, Schuller, J, Mercer, A J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363902/
https://www.ncbi.nlm.nih.gov/pubmed/11308269
http://dx.doi.org/10.1054/bjoc.2001.1747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363902/
https://www.ncbi.nlm.nih.gov/pubmed/11308269
http://dx.doi.org/10.1054/bjoc.2001.1747

Ejemplares similares